These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 7927470
1. [Systemic B-cell response in the mouse after mucosal immunization with measles virus]. Muller CP, Brons NH. Immun Infekt; 1994 Jun; 22(3):125-6. PubMed ID: 7927470 [Abstract] [Full Text] [Related]
2. Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus. Muller CP, Beauverger P, Schneider F, Jung G, Brons NH. J Gen Virol; 1995 Jun; 76 ( Pt 6)():1371-80. PubMed ID: 7782766 [Abstract] [Full Text] [Related]
3. A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice. Chabot S, Brewer A, Lowell G, Plante M, Cyr S, Burt DS, Ward BJ. Vaccine; 2005 Feb 03; 23(11):1374-83. PubMed ID: 15661386 [Abstract] [Full Text] [Related]
4. II. Primary and secondary immunological response of experimental animals to attenuated and nonattenuated measles virus. Aleksandrowicz J, Polna I, Sadowski W. Acta Microbiol Pol A; 1973 Feb 03; 5(3):139-45. PubMed ID: 4203633 [No Abstract] [Full Text] [Related]
5. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. Iankov ID, Pandey M, Harvey M, Griesmann GE, Federspiel MJ, Russell SJ. J Virol; 2006 Sep 03; 80(17):8530-40. PubMed ID: 16912303 [Abstract] [Full Text] [Related]
6. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J. Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689 [Abstract] [Full Text] [Related]
7. Mucosal adenovirus-vectored vaccine for measles. Lobanova LM, Baig TT, Tikoo SK, Zakhartchouk AN. Vaccine; 2010 Nov 10; 28(48):7613-9. PubMed ID: 20887832 [Abstract] [Full Text] [Related]
8. Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies. El Kasmi KC, Fillon S, Theisen DM, Hartter H, Brons NH, Muller CP. J Gen Virol; 2000 Mar 10; 81(Pt 3):729-35. PubMed ID: 10675410 [Abstract] [Full Text] [Related]
9. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration. de Haan A, Haijema BJ, Voorn P, Meijerhof T, van Roosmalen ML, Leenhouts K. Vaccine; 2012 Jul 06; 30(32):4884-91. PubMed ID: 22537989 [Abstract] [Full Text] [Related]
10. Mucosal IgA responses in healthy adult volunteers following intranasal spray delivery of a live attenuated measles vaccine. Simon JK, Ramirez K, Cuberos L, Campbell JD, Viret JF, Muñoz A, Lagos R, Levine MM, Pasetti MF. Clin Vaccine Immunol; 2011 Mar 06; 18(3):355-61. PubMed ID: 21228137 [Abstract] [Full Text] [Related]
11. Measles IgA in the nasal washings of adult volunteers and children immunized intranasally with measles vaccine L-16. Liashenko VA, Krasnova VP, Youminova NV. Hum Antibodies; 1999 Mar 06; 9(3):143-8. PubMed ID: 10690626 [Abstract] [Full Text] [Related]
12. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice. Isaka M, Zhao Y, Nobusawa E, Nakajima S, Nakajima K, Yasuda Y, Matsui H, Hasegawa T, Maeyama J, Morokuma K, Ohkuma K, Tochikubo K. Microbiol Immunol; 2008 Feb 06; 52(2):55-63. PubMed ID: 18380802 [Abstract] [Full Text] [Related]
13. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins. Song MK, Vindurampulle CJ, Capozzo AV, Ulmer J, Polo JM, Pasetti MF, Barry EM, Levine MM. J Virol; 2005 Aug 06; 79(15):9854-61. PubMed ID: 16014946 [Abstract] [Full Text] [Related]
14. Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus. Valosky J, Hishiki H, Zaoutis TE, Coffin SE. Clin Diagn Lab Immunol; 2005 Jan 06; 12(1):171-9. PubMed ID: 15643003 [Abstract] [Full Text] [Related]
15. Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice. de Haan A, Tomee JF, Huchshorn JP, Wilschut J. Vaccine; 1995 Oct 06; 13(14):1320-4. PubMed ID: 8585287 [Abstract] [Full Text] [Related]
16. Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose. Schlereth B, Buonocore L, Tietz A, Meulen VT, Rose JK, Niewiesk S. J Gen Virol; 2003 Aug 06; 84(Pt 8):2145-2151. PubMed ID: 12867646 [Abstract] [Full Text] [Related]
17. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine. Beck M, Smerdel S, Dedić I, Delimar N, Rajninger-Miholic M, Juzbasić M, Manhalter T, Vlatković R, Borcić B, Mihajić Z. Dev Biol Stand; 1986 Aug 06; 65():95-100. PubMed ID: 3556780 [Abstract] [Full Text] [Related]
18. Mucosal inoculation of Lactobacillus expressing hCGbeta induces an anti-hCGbeta antibody response in mice of different strains. Yao XY, Yuan MM, Li DJ. Methods; 2006 Feb 06; 38(2):124-32. PubMed ID: 16414267 [Abstract] [Full Text] [Related]